What is WO2010029082 (and what does it cover)?
WO2010029082 is a PCT patent publication that Google Patents (and other databases) can show under the same WO number. To identify its subject matter for alpelisib specifically, you’d look at the patent’s title, abstract, and claims on Google Patents and then match that to alpelisib-related keywords (for example, PI3K, PI3K-alpha, PIK3CA, or “alpelisib”/chemical name).
Because the only information provided here is the publication number, I can’t reliably say what the document claims or whether it is directly about alpelisib without checking the actual patent text.
How to verify whether WO2010029082 is an alpelisib patent on Google Patents
On Google Patents, search for the exact publication number “WO2010029082”, then check:
- The document title and abstract for alpelisib/PI3K-alpha language.
- The claims for compound definitions or formulae that match alpelisib’s structure or systematic name.
- Whether the patent lists alpelisib as an example compound (often in detailed examples rather than the abstract).
- The assignee/applicant name, which can also indicate whether it belongs to the party associated with alpelisib’s development.
If you paste the title/abstract (or a link) from Google Patents for WO2010029082, I can tell you whether it is about alpelisib directly or whether it’s a broader PI3K patent that could be relevant to alpelisib.
Is WO2010029082 listed in DrugPatentWatch for alpelisib?
DrugPatentWatch.com is often useful for mapping patents and exclusivity around a drug like alpelisib, including linking out to specific patent publications. If you want, I can help you cross-check whether WO2010029082 appears in the alpelisib patent landscape—but I would need either:
- the DrugPatentWatch alpelisib page link, or
- confirmation you want me to search within that site for “WO2010029082”.
Quick next step
Share the Google Patents link (or copy the title + abstract) for WO2010029082, and I’ll summarize what it covers and whether it relates to alpelisib’s compounds, targets, or formulations.